FDA Adverse Event Malfunction Summary report: N

AXSYM TOXO IGG

MDR report key: 2171754 · Received July 22, 2011

Report

Report Number
3002809144-2011-00517
Event Type
Malfunction
Date Received
July 22, 2011
Manufacturer
ABBOTT GERMANY
Product Code
LGD
PMA / PMN Number
K954575
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AN EVALUATION WAS CONDUCTED TO INVESTIGATE THIS ISSUE. SINCE NO RETURNED MATERIALS WERE AVAILABLE FOR THE EVALUATION, A RETAINED KIT OF THE PRODUCT IN QUESTION WAS CALIBRATED AND THE CALIBRATION MET INSTRUMENT SPECIFICATIONS. ALL CONTROL VALUES MET CONTROL SPECIFICATIONS AND WERE IN THE TYPICAL RANGE. THE PRODUCT SENSITIVITY WAS ALSO EVALUATED AND WAS WITHIN MANUFACTURING SPECIFICATIONS. THE COMPLAINT RECORDS FOR THE LOT NUMBER IN QUESTION WAS REVIEWED WITH NO ISSUES IDENTIFIED RELATED TO THIS OBSERVATION. BASED ON THE EVALUATION RESULTS, IT WAS DETERMINED THAT THIS PRODUCT IS PERFORMING WITHIN SPECIFICATIONS AND NO PRODUCT DEFICIENCY WAS IDENTIFIED. THE CUSTOMER WAS INSTRUCTED TO PERFORM A SECOND SEROLOGICAL METHOD FOR IGG ANTIBODIES. WHEN POSITIVE RESULTS ARE OBTAINED WITH THE TWO METHODS, A SUBSEQUENT SERUM SAMPLE TAKEN THREE WEEKS LATER IS TESTED, SO AS TO VERIFY THE PRESENCE OF A POSITIVE AND STABLE TITER OF ANTI T. GONDII IGG ANTIBODIES. IN CASE OF DISCORDANT RESULTS, THE CUSTOMER WAS ADVISED TO CONSIDER THE PATIENT NON IMMUNE AND PERFORM A SEROLOGICAL FOLLOW-UP DURING THE PREGNANCY.

Description of Event or Problem · 1

THE CUSTOMER STATED THAT ONE PATIENT SAMPLE (PREGNANT WOMAN) WITH A HISTORY OF POSITIVE RESULTS FOR THE TOXOPLASMA IGG (ON A NON-ABBOTT METHOD) GENERATED FALSE NEGATIVE RESULTS ON THE AXSYM ANALYZER. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AXSYM TOXO IGG LGD ABBOTT GERMANY

Patients

Seq Age Sex Outcome Treatment
1 AXSYM ANALYZER 7A83-78